Literature DB >> 3022532

Long-term culture of human corticotropin-secreting adenomas on extracellular matrix and evaluation of serum-free conditions. Morphological aspects.

M Westphal, P Jaquet, C B Wilson.   

Abstract

Tissues from 12 human corticotropin-secreting adenomas, obtained during transsphenoidal surgery for Cushing's disease (CD, ten cases) or Nelson's syndrome (NS, two cases), were mechanically dispersed. The resulting single cells and cell aggregates were plated on extracellular matrix derived from bovine corneal endothelia. CD and NS cells showed distinct morphological differences initially, CD cells being much more spherical than the flattened NS cells. By 10 days at the latest after plating, however, CD and NS cells were indistinguishable morphologically. Cultured cells from both entities responded with rounding to cortisol (hydrocortisone, 10(-6) M) within 4-6 h. Synthetic ovine corticotropin-releasing factor (10(-8) M) produced flattening and extension of cytoplasmic processes after as early as 2 h.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3022532     DOI: 10.1007/bf00687976

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  18 in total

1.  Preparation of epidermal growth factor.

Authors:  S Cohen; C R Savage
Journal:  Methods Enzymol       Date:  1975       Impact factor: 1.600

2.  Differential and integral corticosteroid feedback effects on ACTH secretion in hypoadrenocorticism.

Authors:  H L Fehm; K H Voigt; G Kummer; R Lang; E F Pfeiffer
Journal:  J Clin Invest       Date:  1979-02       Impact factor: 14.808

3.  Scanning electron microscopy of rat neurointermediate lobe cells in culture.

Authors:  A E Zimmerman; J V Milligan; M G Joneja
Journal:  Acta Anat (Basel)       Date:  1981

Review 4.  Role of cytoskeletal organization in the regulation of adenylate cyclase-cyclic adenosine monophosphate by hormones.

Authors:  U Zor
Journal:  Endocr Rev       Date:  1983       Impact factor: 19.871

5.  Human prolactin secreting adenoma cells maintained on extracellular matrix.

Authors:  C L Bethea; R I Weiner
Journal:  Endocrinology       Date:  1981-01       Impact factor: 4.736

6.  Concomitant secretion of adrenocorticotropin, beta-endorphin, and gamma-melanotropin from perfused pituitary tumor cells of Cushing's disease: effects of lysine vasopressin, rat median eminence extracts, thyrotropin-releasing hormone, and luteinizing hormone-releasing hormone.

Authors:  S Oki; K Nakao; I Tanaka; K Horii; Y Nakai; S Shimbo; M Watanabe; T Nakane; A Kuwayama; N Kageyama; H Imura
Journal:  J Clin Endocrinol Metab       Date:  1981-01       Impact factor: 5.958

7.  Beta-adrenergic stimulation of prolactin release from superfused pituitary cell aggregates.

Authors:  C Denef; M Baes
Journal:  Endocrinology       Date:  1982-07       Impact factor: 4.736

8.  Radioimmunoassay detection of endorphins from long-term culture of human pituitary tumour cells.

Authors:  B Sharp; S Melmed; R Goldberg; H E Carlson; S Refetoff; J M Hershman
Journal:  Acta Endocrinol (Copenh)       Date:  1982-02

9.  Factors controlling the proliferative rate, final cell density, and life span of bovine vascular smooth muscle cells in culture.

Authors:  D Gospodarowicz; K Hirabayashi; L Giguère; J P Tauber
Journal:  J Cell Biol       Date:  1981-06       Impact factor: 10.539

Review 10.  Role of collagenous matrices in the adhesion and growth of cells.

Authors:  H K Kleinman; R J Klebe; G R Martin
Journal:  J Cell Biol       Date:  1981-03       Impact factor: 10.539

View more
  2 in total

1.  Human anterior pituitary adenoma cell attachment in vitro.

Authors:  S L Atkin; L Hipkin; R V Jeffreys; P M Foy; M C White
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-03       Impact factor: 2.416

2.  A novel human tumoroid 3D model of sustained ACTH-secreting cell cultures to study critically needed therapies for Cushing's disease.

Authors:  Antonio C Fuentes-Fayos; Raúl M Luque
Journal:  EBioMedicine       Date:  2021-05-13       Impact factor: 8.143

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.